Intratympanic corticosteroids for Meniere's disease and vertigo

Otolaryngologic Clinics of North America

Volumn 37, Issue 5, 2004, Pages 955-972

  Barrs, David M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; ANTIBIOTIC AGENT; ANTIOXIDANT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; ETANERCEPT; FLUOROURACIL; GENTAMICIN; GLUCOCORTICOID; GLUTAMATE RECEPTOR ANTAGONIST; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHOTREXATE; METHYLPREDNISOLONE; MINERALOCORTICOID; NEUROTROPHIN; PREDNISOLONE; TACROLIMUS;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; COCHLEA FENESTRA; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; EARDRUM PERFORATION; HEARING LOSS; HUMAN; INNER EAR; INNER EAR DISEASE; MASTOIDITIS; MEDICAL PRACTICE; MEDICAL SPECIALIST; MEMBRANE PERMEABILITY; MENIERE DISEASE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OTITIS MEDIA; OTOTOXICITY; PERCEPTION DEAFNESS; PHARMACEUTICAL CARE; REVIEW; TINNITUS; TREATMENT INDICATION; TREATMENT OUTCOME; VERTIGO;

ADMINISTRATION, TOPICAL; GLUCOCORTICOIDS; HUMANS; MENIERE'S DISEASE; ROUND WINDOW; TYMPANIC MEMBRANE; VERTIGO;

EID: 5044238496     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2004.03.004     Document Type: Review

References (82)

1. Chrousos G.P., Margioris A.N. Adrenocorticosteroids and adrenocortical antagonists. Katzung B.G. Basic and clinical pharmacology. 8th edition :2001;660-678 Lange Medical Books/McGraw-Hill, New York
2. Schimmer B.P., Parker K.L. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. Hardman J.G., Limbird L.E. Goodman & Gilman's the pharmacological basis of therapeutics. 10th edition :2001;1649-1677 McGraw-Hill Medical Publishing Division, New York
3. Gold R., Buttgereit F., Toyka K.V. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol. 117:2001;1-8
4. Hartung H.-P., Kieseier B.C. Autoimmunity in the nervous system. Noseworthy J.H. Neurological therapeutics: principles and practice. Vol. 1:2003;1094-1106 Martin Dunitz, London
5. Rarey K.E., Curtis L.M., ten Cate W.J. Tissue specific levels of glucocorticoid receptor within the rat inner ear. Hear Res. 64:1993;205-210
6. ten Cate W.J., Curtis L.M., Small G.M., Rarey K.E. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. Laryngoscope. 103:1993;865-871
7. Pitovski D.Z., Drescher M.J., Drescher D.G. Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res. 77:1994;216-220
8. Rarey K.E., Curtis L.M. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg. 115:1996;38-41
9. Nagura M., Iwasaki S., Wu R., Mizuta K., Umemura K., Hoshino T. Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol. 366:1999;47-53
10. Shirwany N.A., Seidman M.D., Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol. 19:1998;230-235
11. Trune D.R., Kempton J.B. Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(1pr) autoimmune mice. Hear Res. 155:2001;9-20
12. Lohuis P.J., Borjesson P.K., Klis S.F., Smoorenburg G.F. The rat cochlea in the absence of circulating adrenal hormones: an electrophysiological and morphological study. Hear Res. 143:2000;189-196
13. Lee J.H., Marcus D.C. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiol Neurootol. 7:2002;100-106
14. Goycoolea M.V. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 121:2001;437-447
15. Goycoolea M.V., Lundman L. Round window membrane: structure function and permeability: a review. Microsc Res Tech. 36:1997;201-211
16. Chandrasekhar S.S., Rubinstein R.Y., Kwartler J.A., Gatz M., Connelly P.E., Huang E., et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 122:2000;521-528
17. Saijo S., Kimura R.S. Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol. 97:1984;593-610
18. Salt A.N., Ma Y. Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res. 154:2001;88-97
19. Kawauchi H., DeMaria T.F., Lim D.J. Endotoxin permeability through the round window. Acta Otolaryngol Suppl. 457:1989;100-115
20. Witte M.C., Kasperbauer J.L. Round window membrane permeability to transforming growth factor-α: an in vitro study. Otolaryngol Head Neck Surg. 123:2000;91-96
21. Chelikh L., Teixeira M., Martin C., Sterkers O., Ferrary E., Couloigner V. High variability of perilymphatic entry of neutral molecules through the round window. Acta Otolaryngol. 123:2003;199-202
22. Parnes L.S., Sun A.H., Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 109:1999;1-17
23. Bachmann G., Su J., Zumegen C., Wittekindt C., Michel O. [Permeability of the round window membrane for prednisolone-21-hydrogen succinate: prednisolone content of the perilymph after local administration vs systemic injection]. HNO. 49:2001;538-542. [in German]
24. Plontke S.K., Salt A.N. Quantitative interpretation of corticosteroid pharmacokinetics in inner fluids using computer simulations. Hear Res. 182:2003;34-42
25. Hunter B.A., Lee S., Odland R.M., Juhn S.K. Estimation of perilymph concentration of agents applied to the round window membrane by microdialysis. Acta Otolaryngol. 123:2003;453-458
26. Silverstein H., Rowan P.T., Olds M.J., Rosenberg S.I. Inner ear perfusion and the role of round window patency. Am J Otol. 18:1997;586-589
27. Alzamil K.S., Linthicum F.H. Jr. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol. 109:2000;30-32
28. Nordang L., Linder B., Anniko M. Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otol Neurotol. 24:2003;339-343
29. Harris J.P., Ryan A.F. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg. 112:1995;639-653
30. McCabe B.F. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 88:1979;585-589
31. Harris J.P., Woolf N.K., Ryan A.F. Elaboration of systemic immunity following inner ear immunization. Am J Otolaryngol. 6:1985;148-152
32. Harris J.P. Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol. 93:1984;157-162
33. Woolf N.K., Harris J.P. Cochlear pathophysiology associated with inner ear immune responses. Acta Otolaryngol. 102:1986;353-364
34. Ma C., Billings P., Harris J.P., Keithley E.M. Characterization of an experimentally induced inner ear immune response. Laryngoscope. 110:2000;451-456
35. Harris J.P., Keithley E.M. Autoimmune inner ear disease. Snow J.B. Jr., Ballenger J.J. Ballenger's otorhinolaryngology: head and neck surgery. 16th edition :2003;396-407 BC Decker, Hamilton (Ontario)
36. Rahman M.U., Poe D.S., Choi H.K. Autoimmune vestibulo-cochlear disorders. Curr Opin Rheumatol. 13:2001;184-189
37. Stone J.H., Francis H.W. Immune-mediated inner ear disease. Curr Opin Rheumatol. 12:2000;32-40
38. Rahman M.U., Poe D.S., Choi H.K. Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol. 22:2001;619-624
39. Kilpatrick J.K., Sismanis A., Spencer R.F., Wise C.M. Low-dose oral methotrexate management of patients with bilateral Meniere's disease. Ear Nose Throat J. 79:2000;82-83. 86-8, 91-2
40. Rauch S.D. Clinical management of immune-mediated inner-ear disease. Ann N Y Acad Sci. 830:1997;203-210
41. Derebery M.J., Rao V.S., Siglock T.J., Linthicum F.H., Nelson R.A. Meniere's disease: an immune complex-mediated illness? Laryngoscope. 101:1991;225-229
42. Derebery M.J. Allergic and immunologic aspects of Meniere's disease. Otolaryngol Head Neck Surg. 114:1996;360-365
43. Derebery M.J. Allergic management of Meniere's disease: an outcome study. Otolaryngol Head Neck Surg. 122:2000;174-182
44. Itoh A., Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl. 481:1991;617-623
45. Shea J.J. Jr., Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am. 29:1996;353-358
46. Shea J.J. Jr. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 30:1997;1051-1059
47. Barrs D.M., Keyser J.S., Stallworth C., McElveen J.T. Jr. Intratympanic steroid injections for intractable Meniere's disease. Laryngoscope. 111:2001;2100-2104
48. Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Presented at the Western Section Meeting of The Triological Society. Scottsdale, AZ, January 30-February 1, 2004.
49. Committee on Hearing and Equilibrium. Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg. 113:1995;181-185
50. Hamid MA. Intratympanic dexamethasone perfusion in Meniere's disease. Presented at the Spring Meeting of The American Neurotology Society. Palm Desert (CA), May 12, 2001.
51. Hirvonen T.P., Peltomaa M., Ylikoski J. Intratympanic and systemic dexamethasone for Meniere's disease. ORL J Otorhinolaryngol Relat Spec. 62:2000;117-120
52. Sennaroglu L., Sennaroglu G., Gursel B., Dini F.M. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg. 125:2001;537-543
53. Yang G.S., Song H.T., Keithley E.M., Harris J.P. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol. 21:2000;499-504
54. Chen C.Y., Halpin C., Rauch S.D. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 24:2003;728-733
55. Alexiou C., Arnold W., Fauser C., Schratzenstaller B., Gloddek B., Fuhrmann S., et al. Sudden sensorineural hearing loss: does application of glucocorticoids make sense? Arch Otolaryngol Head Neck Surg. 127:2001;253-258
56. Chandrasekhar S.S. Updates on methods to treat sudden hearing loss. Operative Techniques in Otolaryngology-Head & Neck Surgery. 14:2003;288-292
57. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 22:2001;18-23
58. Gianoli G.J., Li J.C. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg. 125:2001;142-146
59. Kopke R.D., Hoffer M.E., Wester D., O'Leary M.J., Jackson R.L. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol. 22:2001;475-479
60. Arriaga M.A., Goldman S. Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope. 108:1998;1682-1685
61. Silverstein H., Choo D., Rosenberg S.I., Kuhn J., Seidman M., Stein I. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J. 75:1996;468-471. 474, 476
62. Silverstein H., Isaacson J.E., Olds M.J., Rowan P.T., Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 19:1998;196-201
63. Hillman T.M., Arriaga M.A., Chen D.A. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops? Laryngoscope. 113:2003;1903-1907
64. Sakata E., Ito Y., Itoh A. Clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J. 3:1997;117-121
65. Shulman A., Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int Tinnitus J. 6:2000;10-20
66. Spandow O., Anniko M., Hellstrom S. Hydrocortisone applied into the round window niche causes electrophysiological dysfunction of the inner ear. ORL J Otorhinolaryngol Relat Spec. 51:1989;94-102
67. Ikeda K., Morizono T. Effects of ototopic application of a corticosteroid preparation on cochlear function. Am J Otolaryngol. 12:1991;150-153
68. Harner S.G., Driscoll C.L., Facer G.W., Beatty C.W., McDonalt T.J. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol. 22:2001;210-214
69. Quaranta A., Marini F., Sallustio V. Long-term outcome of Meniere's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol. 3:1998;54-60
70. Green J.D. Jr., Blum D.J., Harner S.G. Longitudinal followup of patients with Meniere's disease. Otolaryngol Head Neck Surg. 104:1991;783-788
71. Silverstein H., Smouha E., Jones R. Natural history vs surgery for Meniere's disease. Otolaryngol Head Neck Surg. 100:1989;6-16
72. Thomsen J., Bretlau P., Tos M., Johnsen N.J. Placebo effect in surgery for Meniere's disease: a double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol. 107:1981;271-277
73. Welling D.B., Nagaraja H.N. Endolymphatic mastoid shunt: a reevaluation of efficacy. Otolaryngol Head Neck Surg. 122:2000;340-345
74. Hoffer M.E., Allen K., Kopke R.D., Weisskopf P., Gottshall K., Wester D. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope. 111:2001;1343-1357
75. Silverstein H. Use of a new device, the MicroWick, to deliver medication to the inner ear. Ear Nose Throat J. 78:1999;595-598. 600
76. Jackson L.E., Silverstein H. Chemical perfusion of the inner ear. Otolaryngol Clin North Am. 35:2002;639-653
77. Brown J.N., Miller J.M., Altschuler R.A., Nuttall A.L. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res. 70:1993;167-172
78. Lehner R., Brugger H., Maassen M.M., Zenner H.P. A totally implantable drug delivery system for local therapy of the middle and inner ear. Ear Nose Throat J. 76:1997;567-570
79. Hoffer M.E., Balough B., Henderson J., DeCicco M., Wester D., O'Leary M.J., et al. Use of sustained release vehicles in the treatment of Meniere's disease. Otolaryngol Clin North Am. 30:1997;1159-1166
80. Barrs DM. Practical applications of transtympanic therapy. Presented at the Fall Meeting of The American Neurotology Society. Denver, September 8, 2001.
81. Harris J.P., Weisman M.H., Derebery J.M., Espeland M.A., Gantz B.J., Gulya A.J., et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA. 290:2003;1875-1883
82. Wang X., Truong T., Billings P.B., Harris J.P., Keithley E.M. Blockage of immune-mediated inner ear damage by etanercept. Otol Neurotol. 24:2003;52-57